Clinical Trial Update: USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases [Phase 3]

View source ↗

Summary

This completed Phase 3 trial evaluated USPIO-enhanced and diffusion-weighted MRI for detecting pelvic lymph node metastases in patients with prostate or bladder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Prostate Cancer

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Prostate Cancer, Bladder Cancer | Phase 3 | Status: COMPLETED